Invesco’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $745K | Buy |
272,981
+107,335
| +65% | +$293K | ﹤0.01% | 2982 |
|
|
2025
Q1 | $278K | Buy |
165,646
+117,144
| +242% | +$197K | ﹤0.01% | 3372 |
|
|
2024
Q4 | $79.1K | Buy |
48,502
+1,322
| +3% | +$2.16K | ﹤0.01% | 3635 |
|
|
2024
Q3 | $196K | Buy |
47,180
+896
| +2% | +$3.73K | ﹤0.01% | 3507 |
|
|
2024
Q2 | $253K | Buy |
46,284
+5,200
| +13% | +$28.4K | ﹤0.01% | 3534 |
|
|
2024
Q1 | $411K | Sell |
41,084
-72,310
| -64% | -$723K | ﹤0.01% | 3402 |
|
|
2023
Q4 | $463K | Buy |
113,394
+8,479
| +8% | +$34.6K | ﹤0.01% | 3256 |
|
|
2023
Q3 | $406K | Buy |
104,915
+1,383
| +1% | +$5.35K | ﹤0.01% | 3293 |
|
|
2023
Q2 | $617K | Sell |
103,532
-3,370
| -3% | -$20.1K | ﹤0.01% | 3121 |
|
|
2023
Q1 | $350K | Buy |
106,902
+68,675
| +180% | +$225K | ﹤0.01% | 3431 |
|
|
2022
Q4 | $151K | Sell |
38,227
-227
| -0.6% | -$897 | ﹤0.01% | 3736 |
|
|
2022
Q3 | $231K | Sell |
38,454
-711,744
| -95% | -$4.28M | ﹤0.01% | 3605 |
|
|
2022
Q2 | $4.82M | Buy |
750,198
+713,005
| +1,917% | +$4.58M | ﹤0.01% | 2298 |
|
|
2022
Q1 | $307K | Buy |
37,193
+1,280
| +4% | +$10.6K | ﹤0.01% | 3594 |
|
|
2021
Q4 | $556K | Buy |
35,913
+6,184
| +21% | +$95.7K | ﹤0.01% | 3312 |
|
|
2021
Q3 | $669K | Buy |
+29,729
| New | +$669K | ﹤0.01% | 3263 |
|
|
2021
Q2 | – | Sell |
-24,633
| Closed | -$824K | – | 3996 |
|
|
2021
Q1 | $824K | Buy |
+24,633
| New | +$824K | ﹤0.01% | 3106 |
|